33rd European Cystic Fibrosis Conference Valencia, Spain 16

33rd European Cystic Fibrosis Conference
Valencia, Spain
16-19 June 2010
Poster e comunicazioni orali (*)
(Journal of Cystic Fibrosis 2010; 9 (Supplement 1))
Genetics
2 – Expression and DNA methylation of ENaC genes.
M. Lucarelli1, F. Ceci1, G. Truglio1, S. Pierandrei1, E. Carofiglio2, F. Ascenzioni2, S. Quattrucci3, R.
Strom1. 1Sapienza University of Rome, Dept. Of Cellular Biotechnology and Haematology, Rome,
Italy; 2Sapienza University of Rome, Dept. of Development and Cellular Biology, Rome, Italy;
3
Sapienza University of Rome, Dept. of Pediatrics and Cystic Fibrosis Center of Lazio Region,
Rome, Italy.
6* - mRNA analysis of CFTR. A diagnostic approach.
L. Costantino1, L. Claut2, V. Paracchini1, D.A. Coviello1, C. Colombo2, L. Porcaro1, P. Capasso1, D.
Degiorgio1, M. Seia1. 1Fondazione IRCCS Ca’ Granda, Medical Genetics Laboratory, Milan, Italy;
2
Fondazione IRCCS Ca’ Granda, Cystic Fibrosis Center, Milan, Italy.
Screening & Diagnosis
20 – Different algorithms for CF newborn screening (NBS): a retrospective evaluation.
C. Corbetta1, G. Zani2, T. Mariani1, M. Sangiovanni1, M. Seia3, R.F. Padoan2. 1Regional Newborn
Screening Laboratory, AO ICP, mIlano, Italy; 2CF Support Centre, AO Spedali Civili, Brescia,
Italy; 3Molecular genetic Laboratory, Fondazione PO-MA-RE, Milano, Italy.
36 – CFTR-related disease: clinical charcterization and long term follow up.
L. Claut1, D. Costantini1, N. Faelli1, V. Motta1, L. Costantino2, C. Colombo1. 1Dept of Pediatrics,
CF Center, Fond. IRCCS Ca’ Granda Osp. Maggiore Policlinico University of Milan, Milan, Italy;
2
Medical Genetics Lab, Fund. IRCCS Ca’ Granda Osp. Maggiore Policlinico, University of Milan,
Milan, Italy.
48* - Parthenogenetic activation of human oocytes as a model of polar bodies PGD feasibility for
CF.
V. Paracchini1, A. Paffoni2, S. Ferrari2, L. Costantino1, P. Capasso1, L. Porcaro1, C. Colombo1, D.A.
Coviello1, G. Ragni2, M. Seia1. 1Fondazione IRCCS Ca’ Granda, medical genetics Laboratory,
Milan, Italy; 2Fondazione IRCCS Ca’ Granda, Department of Obstetrics, Gynecology, and
neonatology, Infertility Unit, Milan, Italy; 3Fondazione IRCCS Ca’ Granda, Cystic Fibrosis Center,
Milan, Italy
CFTR Cell Biology/Cell Physiology
New Therapies
Microbiology
107 – Chromogenic versus cetrimide-based media for Pseudomonas aeruginosa isolation
N. Ravenni, D. Dolce, P. Cocchi, C. Braggion, S. Campana. Cystic Fibrosis Center of Florence,
Department of Pediatrics, Florence, Italy.
110 – Epidemiology of first/new Pseudomonas aeruginosa infection in cystic fibrosis patients.
L. Zavataro1, G. Taccetti1, L. Cariani2, N. Ravenni1, G. Braccini1, S. Bresci1, F. Trevisan1, C.
Braggion1, S. Campana1, Italian Group for Early Eradication Treatment. 1CF Center, Meyer
Children’s Hospital, Florence, Italy; 2CF Center Microbiology Laboratory, Milan, Italy.
125 – Molecular characterization of MRSA involved in persistent lung infections in cystic fibrosis
patients: emergence of epidemic clones.
P. Cocchi, G. taccetti, F. Trevisan, C. Braggion, S. Campana. Cystic Fibrosis Center of Florence,
Florence, Italy.
143 – Influenza A/H1N1in patients with cystic fibrosis in Italy: a multicenter survey of the Italian
CF Society.
C. Colombo1, V. Lucidi2, M. Collura3, V. Terlizzi4, E. Bignamini5, B.M. Assael6, S. Quattrucci7, R.
Gagliardini8, A. Manca9, L. Ratclif10, D. Salvatore11, G. Magazzù12, R. Padoan13, F. Poli14, A.
Negri15, G. Pizzamiglio16, V. Motta1, T. Repetto17. 1CF Center of Milano, Milano, Italy; 2CF Center
of Roma Bambino Gesù, Roma, Italy; 3CF Center of Palermo, Palermo, Italy; 4CF Center of Napoli,
Napoli, Italy; 5CF Center of Torino, Torino, Italy; 6CF Center of Verona, Verona, Italy; 7CF Center
of Roma La Sapienza, Roma, Italy; 8CF Center of Ancona, Ancona, Italy; 9CF Center of Bari, Bari,
Italy; 10CF Center of Cerignola, Cerignola, Italy; 11CF Center of Potenza, Potenza, Italy; 12CF
Center of Messina, Messina, Italy; 13CF Center of Brescia, Brescia, Italy; 14CF Center of Trieste,
Trieste, Italy; 15CF Center of Livorno, Livorno, Italy; 16CF ADult Center of Milano, Milano, Italy;
17
CF Center of Firenze, Firence, Italy.
153 – Early Pseudomonas aeruginosa infection: is suceptibility testing justified?
D. Macdonald1, J. Govan1, L. Cuthbertson1, C. Doherty1, S. Campana2, D. Dolce2, G. Taccetti2.
1
University of Edinburgh Medical School, Edinburgh, United Kingdom; 2CF Center Meyer
Hospital, Florence, Italy.
Immunology/Inflammation
184 – Plasma chitotriosidase activity in cystic fibrosis patients.
L. Minicucci1, A. De Alessandri1, R. Casciaro1, B. Tambroni1, S. Notarnicola1, M. Muraca1, M.
Stroppiano2. 1G. Gaslini Institute, CF Center, Genova, Italy; 2G. Gaslini Institute, Pre and Post
Natal Diagnosis Lab, Genova, Italy.
186 – Oxidative status in cystic fibrosis and oral supplementary cysteine.
A. De Alessandri, M. P. Ierardi, R. Casciaro, C. Zucchi, N. Fratangeli, K. Perri, L. Minicucci. G.
Gaslini Institute, CF Center, genova, Italy.
193 – Cytokine profiles in different matrices before and after therapy for acute exacerbation in
cystic fibrosis (CF) patients.
N. Faelli1, A.S. Tirelli2, D. Costantini1, A. Biffi1, V. Motta1, M. Conese3, C. Colombo1. 1Cystic
Fibrosis Centre, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policlinico, Milan, Italy;
2
Laboratory of Clinical Pathology, Fondazione IRCCS Ca’ Granda-Ospedale Maggiore Policnico,
Milan, Italy; 3Department of Biomedical Sciences, University of Foggia, Foggia, Italy.
Pulmonology
200 – Role of Aspergillus fumigatus colonization in the evolution of lung injury in CF patients.
F. Alghisi, S. Zecca, S. Bella, V. Lucidi. Bambino gesù Children’s Hospital – IRCCS, Rome, Italy.
212 – Isolation and characterization of microparticles in sputum from cysti fibrosis patients.
C. Porro1, S. Lepore1, T. Trotta1, S. Castellani1, L- Ratclif2, S. Di Gioia1, M.C. Martinez3, M.
Conese1, A.B. Maffione1. 1University of Foggia, Department of Biomedical Sciences, Foggia, Italy;
2
Centro Regionale di Supporto FC, Ospedale “G. Tatarella”, Cerignola (Foggia), Italy; 3Universitè
d’Angers, CNRS UMR 6214, INSERM U 771, Angers, France.
226 – Obstructive sleep apnea and nocturnal hypoventilation in adults and children with cystic
fibrosis.
C. Sciuto, L. Spicuzza, L. tardino, L. R. Mario. UO Broncopneumologia Pediatrica, Dip di
pediatria, Catania, Italy.
238 – Is telemedicine useful in home management of cystic fibrosis patients?
S. Bella, E. Murgia, F. Alghisi, V. Lucidi. Bambino gesù Pediatric Hospital – IRCCS, Pediatric
Medicine department, Rome, Italy.
240 – Hyaluronic acid in the prevention of bronchial obstruction induced by hypertonic saline.
U. Pradal, A. Borruso, E. Salonini, E. Fedrigo, L. Menin, C. Tartali, B.M. Assael. Cystic Fibrosis
Center, Verona, Italy.
245 – Hyaluronic acid improve tolerability of hypertonic saline in CF patients.
P. Buonpensiero, F. De Gregorio, A. Sepe, A. Di pasqua, P. Ferri, M. Siano, V. Raia. Università
degli Studi di Napoli Federico II, pediatrics, Naples, Italy.
247 – Inhaled hypertonic saline effect on nutritional status.
A. Fogazzi1, F. Timelli1, L. Conforti1, A. Zorzi1, C. Brun1, C. Sottini1, R. Padoan2. 1UO
Riabilitazione Specialistica, AO Spedali Civili, Brescia, Italy; 2Cystic Fibrosis Support Centre, AO
Spedali Civili, Brescia, Italy.
250 – 12 years of spirometry in CF patients with lung transplantation: the experience o fan Italian
regional center.
A.M. Ferrazzi, G. Cimino, S. bertasi, M. Rolla, D. Russo, P. Troiani, F. Patriarchi, S. Quattrucci.
University of Rome “Sapienza”, Department of pediatrics, Rome, Italy.
Physiotherapy
Gastrointestinal/Liver Disease/Metabolic Complication of CF/Nutrition
321* - Insulin secretion, lung function and nutritional status in normal glucose tolerance cystic
fibrosis patients.
G. Alicandro1, A. Battezzati2, L. Zazzeron L1, C. Colombo3. 1Fondazione IRCCS Ca’ Granda
Ospedale Maggiore Policlinico University of Milan, Department of Pediatrics CF Centre, Milan,
Italy; 2International Center for the Assessment of Nutritional Status (ICANS), University of Milan,
Milan, Italy; 3Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico University of Milan,
Department of Pediatrics, CF Centre, Milan, Italy.
341 – Dietary intake and DXA total body measurements in children and adolescents with cystic
fibrosis.
S. Cordioli, S. Perlini, S. Volpi, C. D’Orazio, G. Amenta, B.M. Assael. Cystic Fibrosis Center,
Verona, Italy.
358 – Oxidative stress in stable CF patients: do we need higher antioxidant plasma levels?
A. Lezo1, F. Biasi2, B. Santini3, P. Massarenti4, R. Calabrese3, E. Bignamini5. 1ASO OIRM-S.
ANNA, Clinical Nutrition, Turin, Italy; 2University of Turin, Clinical Biological Sciences, Turin,
Italy; 3University of Turin, Pediatric Sciences, Turin, Italy; 4AOU San Giovanni Battista,
Laboratory of Clinical Chemistry, Turin, Italy; 5ASO OIRM – S. ANNA, Cystic Fibrosis Center of
Piemonte Valle d’Aosta, Turin, Italy.
Nursing and Psychosocial Issues
368* - The International Depression and Anxiety Epidemiological Study (TIDES): results from
Italy.
P. Catastini1, F. Festini2, S. Di Marco3, C. Genovese4, A. Grande5, E. iacinti6, D. Iusco7, R. Nobili8,
R. Pescini9, R. Ragni10, C. Risso11, P. Tabarini12, G. Biondi12. 1CF Center, Firenze, Italy; 2Florence
University, Pediatric Depart, Firenze, Italy; 3CF Center, Palermo, Italy; 4CF Center, Potenza, Italy;
5
CF Adult Center, Torino, Italy; 6CF Center, Parma, Italy; 7CF Center, Bari, Italy; 8CF Center,
Milano, Italy; 9CF Center, genova, Italy; 10CF Center, Ancona, Italy; 11CF Child Center, Torino,
Italy; 12CF Center, Roma, Italy.
381* - Quality of life (HRQoL) in cystic fibrosis: the parents’ perception and the comparison with
children’s QoL.
F. Alghisi1, V. Di Ciommo2, E. Mazzotti2,3, V. Lucidi1, L. Ravà2, M. Cuttini2. 1Bambino Gesù
Children’s Hospital – IRCCS, Unit of Cystic Fibrosis, Rome, Italy; 2Bambino Gesù Children’s
Hospital – IRCCS, Unit of Epidemiology, Rome, Italy; 3Dermatological Institute IDI – IRCCS,
Rome, Italy.
401 – Contraception and sexual awareness in patients with cystic fibrosis.
P. Catastini, T. Fantoni, E. Lattughi, M. Picchi. CF Center, Meyer Hospital, Florence University,
Firenze, Italy.
406 – Domiciliary assistance in cystic fibrosis: the experience of a regional center.
F. Patriarchi, T. Tonelli, F. Annese, B. Giacomodonato, D. Russo, A. Monni, A.M. Ferrazza, F.
Alatri, S. Quattrucci. University of Rome “Sapienza”, Department of Pediatrics, Rome, Italy.
Epidemiology/Registry
424* - Differences in disease severity of 508del homozygotes across European countries.
A. Zolin1, L. Viviani1, H. Holesen2, E. Kerem3, A. Bossi1. 1Statistica Medica e Biometria “G.A.
Maccacaro”, Milan, Italy; 2Aarhus University Hospital Skejby, Cystic Fibrosis Center, Skejby,
Aarhus, Denmark; 3Hadassah-Hebrew Univeristy Medical Center, Mount Scopus, Department of
Pediatrics, Jerusalem, Israel.
438 – Pharmacoeconomic evaluation of cystic fibrosis (CF) inItaly: an observational propective
cohort study.
C. Lucioni1, R. Ravasio1, F. Bianco2, S. Loi3, R. Buzzetti4, C. Colombo3. 1Wolters Kluwer Health,
Milano, Italy; 2Chiesi Farmaceutici Spa, Medical Department, Parma, Italy; 3Centro Fibrosi Cistica
– Fondazione IRCCS, Milano, Italy; 4Clinical Epidemiologist, Rimini, Italy.
Other Issues
455 – Paranasal sinus mucoceles in children with cystic fibrosis.
R. Padoan1, G. Cattaneo1, S. Timpano1, D. Tonni2, M. Berlucchi2. 1CF Support Centre, AO Spedali
Civili, Brescia, Italy; 2University of Brescia, Dept. Of Otorhinlaryngology, Brescia, Italy.
Case Reports
462 – Temocillin: time to rediscover it?
A. Amaddeo1, F. Poli1, E. Barbi2, I. L’Erario2. 1IRCCS Burlo Garofalo, Cystic Fibrosis Centre,
Trieste, Italy; 2IRCCS Burlo Garofalo, Trieste, Clinica Pediatrica, Trieste, Italy.
463 – Non invasive ventilation (NIV) and pregnancy.
S. Bresci1, S. Gambazza1, D. Innocenti1, F. Mecacci2, P. D’Onofrio3, M.P. Rambaldi2, C.
Braggion1. 1AOU Meyer, Cystic Fibrosis, Florence, Italy; 2AOU Careggi, Gynecology, Florence,
Italy; 3AOU Careggi, Anaesthesia, Florence, Italy.
*: Presentazione orale.